According to Pfizer's latest preliminary results from Phase 2b clinical trials, after adjustment for placebo, the average weight loss rate of Danuglipron at 32 weeks ranged from -8% to -13%, and at 26 weeks it ranged from -5% to -9.5%
You can ask questions about side effects , dosing concerns, or treatment adjustments without paying per-message fees
Our experienced medical team creates personalized treatment plans designed to help reduce appetite, support healthy weight loss, and improve overall wellness
The Five-to-One Fiber Rule Juicing Removes More Than Just Fiber For more on GLP-1, see my book OZEMPIC: Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs
It works as both a corrective treatment and a proactive step before starting GLP-1 agonists